Memantine mitigates methamphetamine-induced impairments in social and recognition memories in rats

Mehdi Khodamoradi1, Yasaman Allameh2, Melika Sarani3

  • 1Substance Abuse Prevention Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.

BMC Neuroscience
|June 5, 2025
PubMed
Abstract

Insights

Memantine (MEM) treatment reversed memory and social behavior deficits caused by methamphetamine (METH) neurotoxicity. This study shows MEM

Area of Science:

  • Neuroscience
  • Pharmacology
  • Toxicology

Background:

  • Methamphetamine (METH) is a neurotoxic substance linked to cognitive disabilities.
  • Memantine (MEM), an NMDA receptor antagonist, shows potential in improving cognitive function.
  • METH exposure is known to cause social and cognitive impairments.

Purpose of the Study:

  • To investigate MEM's effects on social memory, social behavior, and novel object recognition impairments induced by chronic METH exposure.
  • To evaluate MEM's neuroprotective potential against METH-induced neurotoxicity.

Main Methods:

  • Adult male Wistar rats were administered METH to induce neurotoxicity.
  • Following METH exposure, rats were treated with MEM.
  • Novel object recognition memory and social behaviors were assessed.

Main Results:

  • METH exposure significantly impaired novel object recognition memory (acquisition, consolidation, retrieval).
  • MEM treatment ameliorated METH-induced deficits in memory, but not reconsolidation.
  • MEM improved METH-triggered deficits in social interaction and behavior.

Conclusions:

  • MEM administration effectively ameliorated memory impairments caused by chronic METH exposure.
  • MEM demonstrated neuroprotective effects on novel object memory, social memory, and social behaviors.
  • Findings suggest MEM as a potential therapeutic agent for METH-induced neurocognitive deficits.